Sinon Corporation (1712.TW)
TWD 43.1
(-0.58%)
TWD 43.1
(-0.58%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.05 Billion TWD | -36.21% |
| 2022 | 1.65 Billion TWD | 79.21% |
| 2021 | 920.91 Million TWD | 28.69% |
| 2020 | 715.59 Million TWD | 6.04% |
| 2019 | 674.85 Million TWD | -7.17% |
| 2018 | 726.95 Million TWD | 25.76% |
| 2017 | 578.04 Million TWD | 4.25% |
| 2016 | 554.47 Million TWD | 57.19% |
| 2015 | 352.73 Million TWD | -30.36% |
| 2014 | 506.5 Million TWD | 11.12% |
| 2013 | 455.83 Million TWD | 12.12% |
| 2012 | 406.55 Million TWD | 13.46% |
| 2011 | 358.31 Million TWD | 1.68% |
| 2010 | 352.38 Million TWD | -4.34% |
| 2009 | 368.38 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 338.9 Million TWD | 65.02% |
| 2024 Q2 | 230.87 Million TWD | -31.88% |
| 2023 Q4 | 205.37 Million TWD | -17.01% |
| 2023 Q2 | 279.73 Million TWD | -12.65% |
| 2023 Q3 | 247.47 Million TWD | -11.53% |
| 2023 FY | 1.05 Billion TWD | -36.21% |
| 2023 Q1 | 320.26 Million TWD | 37.35% |
| 2022 Q2 | 411.86 Million TWD | -13.46% |
| 2022 FY | 1.65 Billion TWD | 79.21% |
| 2022 Q1 | 475.91 Million TWD | 147.57% |
| 2022 Q3 | 529.42 Million TWD | 28.54% |
| 2022 Q4 | 233.17 Million TWD | -55.96% |
| 2021 Q3 | 260.06 Million TWD | 20.41% |
| 2021 Q2 | 215.98 Million TWD | -14.51% |
| 2021 FY | 920.91 Million TWD | 28.69% |
| 2021 Q1 | 252.64 Million TWD | 105.88% |
| 2021 Q4 | 192.23 Million TWD | -26.08% |
| 2020 Q1 | 20.59 Million TWD | -88.0% |
| 2020 Q4 | 122.71 Million TWD | -42.83% |
| 2020 Q3 | 214.64 Million TWD | -39.98% |
| 2020 FY | 715.59 Million TWD | 6.04% |
| 2020 Q2 | 357.64 Million TWD | 1636.88% |
| 2019 Q1 | 200.3 Million TWD | 39.5% |
| 2019 Q3 | 101.23 Million TWD | -49.83% |
| 2019 Q4 | 171.54 Million TWD | 69.46% |
| 2019 FY | 674.85 Million TWD | -7.17% |
| 2019 Q2 | 201.76 Million TWD | 0.73% |
| 2018 Q2 | 317.18 Million TWD | 117.89% |
| 2018 Q4 | 143.58 Million TWD | 19.05% |
| 2018 FY | 726.95 Million TWD | 25.76% |
| 2018 Q1 | 145.57 Million TWD | 62.68% |
| 2018 Q3 | 120.61 Million TWD | -61.97% |
| 2017 Q1 | 136.4 Million TWD | -17.08% |
| 2017 FY | 578.04 Million TWD | 4.25% |
| 2017 Q2 | 191.6 Million TWD | 40.47% |
| 2017 Q4 | 89.48 Million TWD | -44.27% |
| 2017 Q3 | 160.55 Million TWD | -16.21% |
| 2016 FY | 554.47 Million TWD | 57.19% |
| 2016 Q1 | 160.32 Million TWD | -20.5% |
| 2016 Q4 | 164.5 Million TWD | 86.49% |
| 2016 Q3 | 88.21 Million TWD | -37.63% |
| 2016 Q2 | 141.42 Million TWD | -11.79% |
| 2015 Q4 | 201.66 Million TWD | 1084.24% |
| 2015 FY | 352.73 Million TWD | -30.36% |
| 2015 Q2 | 121.54 Million TWD | 872.66% |
| 2015 Q1 | 12.49 Million TWD | -88.13% |
| 2015 Q3 | 17.02 Million TWD | -85.99% |
| 2014 Q2 | 120.15 Million TWD | -41.02% |
| 2014 Q1 | 203.73 Million TWD | 72.6% |
| 2014 FY | 506.5 Million TWD | 11.12% |
| 2014 Q4 | 105.28 Million TWD | 36.16% |
| 2014 Q3 | 77.32 Million TWD | -35.65% |
| 2013 Q1 | 142.58 Million TWD | 19.27% |
| 2013 FY | 455.83 Million TWD | 12.12% |
| 2013 Q4 | 118.04 Million TWD | -8.42% |
| 2013 Q3 | 128.89 Million TWD | 94.39% |
| 2013 Q2 | 66.3 Million TWD | -53.5% |
| 2012 Q3 | 112.82 Million TWD | 45.49% |
| 2012 Q4 | 119.54 Million TWD | 5.96% |
| 2012 FY | 406.55 Million TWD | 13.46% |
| 2012 Q1 | 106.22 Million TWD | 43.51% |
| 2012 Q2 | 77.54 Million TWD | -27.0% |
| 2011 Q1 | 105.63 Million TWD | 52.76% |
| 2011 Q4 | 74.01 Million TWD | -40.36% |
| 2011 Q3 | 124.11 Million TWD | 127.53% |
| 2011 Q2 | 54.54 Million TWD | -48.36% |
| 2011 FY | 358.31 Million TWD | 1.68% |
| 2010 Q4 | 69.15 Million TWD | 0.78% |
| 2010 Q3 | 68.62 Million TWD | -39.86% |
| 2010 Q1 | 100.51 Million TWD | 0.0% |
| 2010 FY | 352.38 Million TWD | -4.34% |
| 2010 Q2 | 114.09 Million TWD | 13.51% |
| 2009 FY | 368.38 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Taiwan Fertilizer Co., Ltd. | 3.91 Billion TWD | 73.135% |
| All Cosmos Bio-Tech Holding Corporation | 139.36 Million TWD | -655.483% |
| CH Biotech R&D Co., Ltd. | 463.29 Million TWD | -127.254% |